Healthcare Reform for Irish Patients
is that all Irish Patients can afford and access the medicines they need to get well, stay well and live well.
We are dedicated to affordable access to medicine
Medicines for Ireland is a pharmaceutical industry body committed to affecting real change and reforms that guarantee patients across Ireland have access the medicines they need at affordable prices.
Since its foundation in 2016, Medicines for Ireland has been promoting the benefits of the increased use of non-patient medicines (known also as generic, biosimilar, and value-added medicines) in Ireland.
Our members are the suppliers of the majority of medicine in Ireland to the HSE and patients directly.
As an organisation, our core objective is to improve the way Ireland procures and supplies medicines, in order to expand patient access to affordable, lifesaving and life-enhancing treatment.
- Enhance access to safe, high-quality medicines for patients across Ireland at an affordable price.
- Safeguard the supply of medicines to Ireland by helping to ensure supply chains remain secure and reliable.
- Innovate our approach to acquiring, supplying, and distributing medicines nationwide with the dual objective of pushing down costs and delivering greater equality of access for patients.
- Inform key stakeholders of the specific and wider benefits associated with the increased usage of off-patent medicines.
News and Articles
Warnings from GPs and pharmacists on medicine shortages need be taken seriously – Medicines for Ireland
Medicines for Ireland (MFI) are urging Government to heed recent warnings from GPs and pharmacists nationwide on the growing risk of medicines shortages as inflation,
Increasing risk of medicine shortages as suppliers severely impacted by soaring inflation
Medicines for Ireland (MFI) have highlighted the growing risk of medicines shortages as inflation, energy and transport costs continue to rise, and global supply chain
Medicines for Europe warns strongly against energy rationing for medicines production
In line with today’s European Commission’s Guidelines on a European Gas Demand Reduction Plan1, Medicines for Europe urges Governments to maintain energy supply to medicines production sites in the event of energy restrictions in Europe.
Generic medicines now account for almost 60% of the Irish prescription market.
According to findings commissioned by Medicines for Ireland (MFI) and compiled by IQVIA Ireland generic medicines now account for 57% of the volume of the total prescription market in Ireland.
Medicines for Ireland
13 Merrion Square North,